Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Praxis Precision Medicines Inc (NASDAQ: PRAX) closed the day trading at $47.78 up 1.90% from the previous closing price of $46.89. In other words, the price has increased by $1.90 from its previous closing price. On the day, 0.66 million shares were traded. PRAX stock price reached its highest trading level at $50.0 during the session, while it also had its lowest trading level at $45.06.
Ratios:
For a better understanding of PRAX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.39 and its Current Ratio is at 5.39. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 19, 2023, initiated with a Buy rating and assigned the stock a target price of $10.
On June 06, 2022, Wedbush Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $4.
On December 16, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $48.H.C. Wainwright initiated its Buy rating on December 16, 2021, with a $48 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 05 ’23 when DeSimone Jill bought 14,500 shares for $1.75 per share. The transaction valued at 25,375 led to the insider holds 14,500 shares of the business.
Souza Marcio bought 10,000 shares of PRAX for $10,587 on Jun 27 ’23. The Chief Executive Officer now owns 45,002 shares after completing the transaction at $1.06 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRAX now has a Market Capitalization of 816459840 and an Enterprise Value of 541941184. For the stock, the TTM Price-to-Sale (P/S) ratio is 333.29 while its Price-to-Book (P/B) ratio in mrq is 6.03. Its current Enterprise Value per Revenue stands at 221.472 whereas that against EBITDA is -4.303.
Stock Price History:
Over the past 52 weeks, PRAX has reached a high of $67.21, while it has fallen to a 52-week low of $12.45. The 50-Day Moving Average of the stock is -6.03%, while the 200-Day Moving Average is calculated to be 64.43%.
Shares Statistics:
Over the past 3-months, PRAX traded about 192.92K shares per day on average, while over the past 10 days, PRAX traded about 240130 shares per day. A total of 17.09M shares are outstanding, with a floating share count of 16.28M. Insiders hold about 4.72% of the company’s shares, while institutions hold 44.09% stake in the company. Shares short for PRAX as of 1711584000 were 431369 with a Short Ratio of 2.24, compared to 1709164800 on 414785. Therefore, it implies a Short% of Shares Outstanding of 431369 and a Short% of Float of 3.27.
Earnings Estimates
At present, Praxis Precision Medicines, Inc analysts are actively evaluating the performance of Praxis Precision Medicines Inc (PRAX) in the stock market.The consensus estimate for the next quarter is $23.67, with high estimates of $69.10 and low estimates of $14.02.
